ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2591

Hospitalization Among Incident Cases of Systemic Sclerosis: Results from a Population-based Cohort (1980-2016)

Caitrin Coffey1, Avneek Singh Sandhu 2, Cynthia Crowson 3, Sara Achenbach 1, Eric Matteson 4, Thomas Osborn 5, Kenneth Warrington 6 and Ashima Makol 5, 1Mayo Clinic, Rochester, MN, 2kettering health, dayton, OH, 3Mayo Clinic Rochester, Rochester, 4Mayo Clinic College of Medicine and Science, Rochester, Minnesota, USA, Rochester, 5Mayo Clinic Minnesota, rochester, MN, 6Mayo Clinic Rochester, Rochester, MN

Meeting: 2019 ACR/ARP Annual Meeting

Keywords: Scleroderma, systemic sclerosis and Health Care

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 12, 2019

Title: Systemic Sclerosis & Related Disorders – Clinical Poster III

Session Type: Poster Session (Tuesday)

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic sclerosis (SSc) is an autoimmune disorder associated with multi-organ dysfunction, requiring long-term and multi-disciplinary care. Few studies have estimated the healthcare resource usage of patients with SSc. The purpose of this study was to compare hospitalization among incident cases of SSc vs age- and sex-matched comparators.

Methods: A retrospective, population-based cohort of physician-diagnosed patients with SSc in a geographically well-defined area from Jan 1, 1980 to Dec 31, 2016 was identified and utilized for this study. A 2:1 cohort of age- and sex-matched non-SSc subjects from the same population was randomly selected for comparison. Patients who died or emigrated from the area prior to 1987 were excluded. Patients were followed until death, migration from the geographic area or Sep 30, 2018. All hospitalizations in the geographic area from Jan 1, 1987 to Sep 30, 2018 were obtained. Primary discharge diagnosis information was available for hospitalizations in 1995 to present. Readmission was defined as occurring within 30 days of a discharge. Rates of hospitalization of cases and comparators were analyzed using person-year methods and rate ratios. Length of stay was analyzed using generalized linear models adjusted for age, sex and calendar year, with random intercepts to account for multiple hospitalizations per patient.

Results: The cohort included 76 incident SSc cases and 155 non-SSc comparators (mean age of 56 ± 16 years at diagnosis/index, both 91% female). Mean length of follow-up was 11.5 (SD 8.5) years for SSc subjects and 13.3 (SD 8.6) years for comparators. Rates of hospitalization among cases and comparators were 31.9 and 17.9 per 100 person-years, respectively (rate ratio [RR]:1.78; 95% confidence interval (CI):1.52-2.08)(Table). By sex, men (RR:4.33; 95%CI:2.58-7.60) and women (RR:1.63; 95%CI:1.38-1.92) with SSc had substantially higher hospitalization rates than comparators.
Hospitalization rates were higher in SSc compared with non-SSc subjects during the first 5 years after SSc diagnosis (RR: 2.16; 95%CI:1.70-2.74). This difference decreased over time and was no longer significant for ≥15 years after SSc incidence/index (Figure). Patients age 65+ were more frequently hospitalized than younger subjects in both SSc and comparator groups, and the difference in hospitalization rates between groups was largest in those age < 50 years (RR: 2.54: 95% CI: 1.73-3.75).
SSc subjects were more frequently hospitalized for infections and diseases involving circulatory, digestive, and respiratory systems than comparators, with ratios ranging from 1.96 to 3.90. Lengths of stay (median (IQR) 4 (2-6) vs 3(2-6); p=0.52) and readmission rates (25% vs 23%; p=0.51) were similar among cases and comparators.

Conclusion: A higher frequency of hospitalization occurred among patients with SSc compared to non-SSc subjects, indicating high inpatient care needs in this population. Hospitalization rates were highest among SSc subjects during the first 5 years of SSc diagnosis. Hospitalization rates approached those of non-SSc comparators over time after diagnosis, possibly due to confounding by age and other comorbidities.


HospitalizationTable5.31.2019


HospitalizationFigure5.31.2019


Disclosure: C. Coffey, None; A. Sandhu, None; C. Crowson, Crescendo Bioscience, 5, Crescendo BioScience Inc., 5, Crescendo Bioscience Inc., 5, Crescendo Biosciences inc., 5, Pfizer, 2; S. Achenbach, None; E. Matteson, Boehringer Ingelheim, 5, Pfizer, 2, Sun Pharmaceuticals, 2; T. Osborn, None; K. Warrington, Eli Lilly, 2, GlaxoSmithKline, 2, roche, 2, 8, Roche, 2, 5, 8, Sanofi, 5, sanofi, 5; A. Makol, None.

To cite this abstract in AMA style:

Coffey C, Sandhu A, Crowson C, Achenbach S, Matteson E, Osborn T, Warrington K, Makol A. Hospitalization Among Incident Cases of Systemic Sclerosis: Results from a Population-based Cohort (1980-2016) [abstract]. Arthritis Rheumatol. 2019; 71 (suppl 10). https://acrabstracts.org/abstract/hospitalization-among-incident-cases-of-systemic-sclerosis-results-from-a-population-based-cohort-1980-2016/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2019 ACR/ARP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/hospitalization-among-incident-cases-of-systemic-sclerosis-results-from-a-population-based-cohort-1980-2016/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology